| MR编号 | NL/H/3168/001 |
|---|
| 药品名称 | Cortiment 9 mg, prologed release tablets |
|---|
| 活性成分 | |
|---|
| 剂型 | Prolonged-release tablet |
|---|
| 上市许可持有人 | Ferring B.V.
Polarisavenue 130
2132 JX HOOFDDORP |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Cortiment 9 mg, prolonged releales tablets |
|---|
| 互认成员国 - 产品名称 | - Denmark (DK)
- France (FR)
- Germany (DE)
CORTIMENT MMX 9 mg Retardtabletten - Iceland (IS)
Cortiment 9 mg Forðatafla - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
CortimentMMX 9 mg - Retardtabletten - Portugal (PT)
- Italy (IT)
- Greece (GR)
CORTIMENT - Sweden (SE)
- Norway (NO)
Cortiment - Finland (FI)
- Poland (PL)
Cortiment MMX - Latvia (LV)
- Lithuania (LT)
Budesonide Ferring 9 mg pailginto atpalaidavimo tabetės - Estonia (EE)
CORTIMENT - Hungary (HU)
CORTIMENT 9 mg retard tabletta - Bulgaria (BG)
Cortiment - Cyprus (CY)
CORTIMENT PR TABS - Czechia (CZ)
Cortiment 9 MG - Romania (RO)
CORTIMENT 9 mg comprimate cu eliberare prelungita - Slovakia (SK)
CortimentMMX - Slovenia (SI)
- Malta (MT)
CortimentMMX 9mg Prolonged release tablet - Croatia (HR)
Cortiment MMX 9 mg tablete s produljenim oslobađanjem
|
|---|
| 许可日期 | 2014/10/17 |
|---|
| 最近更新日期 | 2024/01/25 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|